Vertex Pharmaceuticals (VRTX) News Today $469.55 +5.35 (+1.15%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$464.74 -4.81 (-1.02%) As of 08:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Vertex Pharmaceuticals Up Today?Toggle Visibility of Why Is Vertex Pharmaceuticals Up Today?Investors in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have been digesting a variety of analyst actions and commentary ahead of the company’s upcoming Q2 report and full-year outlook. Recent updates include earnings estimate revisions, price‐target changes and thematic coverage that may influence VRTX shares. Positive Sentiment: Bank of America Securities reiterated a Buy rating on VRTX, highlighting strong growth driven by cystic fibrosis successes and strategic expansions. Vertex Pharmaceuticals: Strong Growth Driven by Cystic Fibrosis Success and Strategic Expansions Positive Sentiment: Vertex’s price target was raised to $517.00 by analysts, reflecting a more bullish view on the stock’s medium-term potential. Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $517.00 Positive Sentiment: William Blair lifted its Q2 2025 EPS estimate to $4.00 from $3.95, underscoring confidence in Vertex’s near-term revenue drivers. Neutral Sentiment: William Blair outlined its FY 2025 EPS forecast of $16.17 and a FY 2026 estimate of $18.39, while maintaining an Outperform rating. What is William Blair's Forecast for VRTX FY2025 Earnings? Neutral Sentiment: Zacks named VRTX a trending stock, offering key facts on its pipeline positioning and valuation ahead of earnings. Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Neutral Sentiment: Zacks highlighted Vertex among two medical names with strong Earnings ESP, suggesting it could beat upcoming quarterly estimates. These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Neutral Sentiment: An American Banking News roundup detailed various broker expectations for Vertex’s Q2 results, illustrating a range of EPS forecasts. Equities Analysts Offer Predictions for VRTX Q2 Earnings Negative Sentiment: William Blair trimmed its FY 2025 EPS forecast slightly to $16.17 from $16.20, signaling a minor downward revision to its full-year outlook. William Blair Has Negative Outlook for VRTX FY2025 Earnings Posted 1h agoAI Generated. May Contain Errors. VRTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Victory Capital Management Inc. Sells 11,261 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)2 hours ago | marketbeat.comWhat is William Blair's Forecast for VRTX FY2025 Earnings?July 17 at 3:31 AM | americanbankingnews.comTriasima Portfolio Management inc. Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 16 at 8:59 AM | marketbeat.comWelch & Forbes LLC Boosts Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 16 at 8:44 AM | marketbeat.comGrandfield & Dodd LLC Raises Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 16 at 8:34 AM | marketbeat.comSegall Bryant & Hamill LLC Has $25.61 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 16 at 7:54 AM | marketbeat.comBridgewater Advisors Inc. Purchases Shares of 1,113 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 16 at 7:09 AM | marketbeat.comWilliam Blair Has Negative Outlook for VRTX FY2025 EarningsJuly 16 at 6:46 AM | marketbeat.comPAX Financial Group LLC Takes $316,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 16 at 6:44 AM | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $517.00July 16 at 3:01 AM | americanbankingnews.comEquities Analysts Offer Predictions for VRTX Q2 EarningsJuly 16 at 2:21 AM | americanbankingnews.comWealthfront Advisers LLC Increases Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 15 at 8:18 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by West Family Investments Inc.July 15 at 7:54 AM | marketbeat.comWilliam Blair Analysts Lift Earnings Estimates for VRTXJuly 15 at 7:45 AM | marketbeat.comDakota Wealth Management Acquires 2,739 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 15 at 6:38 AM | marketbeat.comSignaturefd LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 15 at 5:58 AM | marketbeat.comVertex Announces Broad Reimbursement Agreement With NHS England for ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic FibrosisJuly 14 at 7:01 PM | businesswire.comVertex Pharmaceuticals (VRTX) Target Price Raised by JP Morgan | VRTX Stock NewsJuly 14 at 12:58 PM | gurufocus.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Vertex Pharmaceuticals (NASDAQ:VRTX) StockJuly 14 at 12:17 PM | marketbeat.comMassachusetts Financial Services Co. MA Has $981.72 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 14 at 9:10 AM | marketbeat.comVertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute PainJuly 14 at 8:30 AM | businesswire.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Apollon Wealth Management LLCJuly 14 at 7:56 AM | marketbeat.comBogart Wealth LLC Sells 3,092 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 14 at 7:41 AM | marketbeat.comCutter & CO Brokerage Inc. Has $4.08 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 14 at 6:52 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Bleakley Financial Group LLCJuly 14 at 6:34 AM | marketbeat.comMy 3 Top Stocks to Buy in a Market That's Highly Volatile (Again)July 14 at 4:44 AM | fool.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Arjuna CapitalJuly 13, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by New York State Common Retirement FundJuly 13, 2025 | marketbeat.comBrown Advisory Inc. Raises Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 13, 2025 | marketbeat.comPenserra Capital Management LLC Has $60,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 13, 2025 | marketbeat.comArizona State Retirement System Purchases 930 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 12, 2025 | marketbeat.comIFC Advisors LLC Invests $269,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 12, 2025 | marketbeat.comHarmony Asset Management LLC Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 12, 2025 | marketbeat.comThe Best Stocks to Invest $1,000 in Right NowJuly 12, 2025 | fool.com10 Brilliant Growth Stocks to Buy Now and Hold for the Long TermJuly 12, 2025 | fool.com5VRTX : Vertex Pharmaceuticals's Options: A Look at What the Big...July 11, 2025 | benzinga.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Diversify Wealth Management LLCJuly 11, 2025 | marketbeat.comXponance Inc. Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 11, 2025 | marketbeat.comGenus Capital Management Inc. Purchases New Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 11, 2025 | marketbeat.comJoseph Group Capital Management Has $3.46 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 11, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Cerity Partners LLCJuly 11, 2025 | marketbeat.comLeavell Investment Management Inc. Buys 1,423 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 11, 2025 | marketbeat.comStratos Wealth Partners LTD. Sells 1,097 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 11, 2025 | marketbeat.com528 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Acquired by Financial Counselors Inc.July 11, 2025 | marketbeat.comEquities Analysts Offer Predictions for VRTX FY2025 EarningsJuly 11, 2025 | americanbankingnews.comVision Capital Management Inc. Increases Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 10, 2025 | marketbeat.comTelos Capital Management Inc. Buys 547 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 10, 2025 | marketbeat.comVRTX FY2025 EPS Estimate Reduced by Cantor FitzgeraldJuly 10, 2025 | marketbeat.comAlpine Woods Capital Investors LLC Has $2.71 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)July 10, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Holdings Decreased by Banque Pictet & Cie SAJuly 10, 2025 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.170.95▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼5830▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amazon.com News Axsome Therapeutics News CRISPR Therapeutics News Alphabet News Intuitive Surgical News Moderna News Repligen News AbbVie News Eli Lilly and Company News Pfizer News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRTX Stock Alerts